SUSAN WALKER V. BAYER CORPORATION ET AL, 96-C 5024 (N.D. III) PAYMENTS (FAM)

SR 98-03 Dated 05/98

Previous Policy

___________________________________________________________

Resources that are a result of payments from the settlement of Susan Walker v. Bayer Corporation et al, 96-c 5024 (N.D. III) which compensates hemophiliacs who contracted the Human Immunodeficiency Virus (HIV) from contaminated blood products.

Treatment:

• For TANF financial assistance, Counted Lump Sum Payment.

• For medical assistance cases, Excluded Resource.